‘World No Tobacco Day’ falls each year on May 31, and the theme chosen by the World Health Organisation (WHO) for 2026 “Unmasking the Appeal: Countering Nicotine and Tobacco Addiction” arrives with particular urgency for Nigeria.
Not because this country is losing the tobacco war on the front that most people associate with the problem, the ageing smoker with a cigarette between his fingers, but because it is losing it on a front it has barely begun to defend: its secondary schools, its social media feeds, and the corner shops where flavoured nicotine pouches sit in bright packaging beside the sweets and biscuits.
The headline numbers on adult smoking in Nigeria carry a deceptive reassurance. Overall tobacco use hovers between four and 5.6 per cent of the adult population, or roughly seven to eleven million regular users. Compared with global averages, that figure appears manageable. What it conceals is the generational shift happening beneath it.
According to data from the National Tobacco Control Authority, nearly one in five Nigerian schoolchildren between the ages of 13 and 15 have already experimented with at least one tobacco product. One in 10 within that same cohort are active smokers today. These are not statistics from some distant health ministry report. They describe children who are, at this moment, in classrooms across Abuja, Lagos, Kano, and Port Harcourt, whose lungs are still developing and whose brains are forming the addictive pathways that the tobacco industry has spent decades learning to exploit.
The industry’s methods deserve plain description. Synthetic nicotine, engineered to deliver sharper hits than natural tobacco. Flavours ,mango, watermelon, mint designed specifically to lower the psychological barrier of first use. Packaging crafted to resemble consumer electronics rather than health products: slim, matte-finished, fitted with USB ports. Digital marketing algorithms that identify adolescent users and serve them targeted content before any parent or regulator can intervene.
The Nigerian Cancer Society, whose President, Prof. Abidemi Omonisi, spoke pointedly on the occasion of this year’s World No Tobacco Day, is right to call these tactics what they are: a deliberate campaign to recruit a new generation of addicts in markets where regulation remains weak and enforcement weaker still.
The health toll, stated plainly, is this: approximately 30,000 Nigerians die each year from tobacco-related diseases. Cardiovascular disease, chronic obstructive pulmonary disease and lung cancer lead the count. The annual economic burden encompassing direct healthcare costs and lost productivity stands at N211.2 billion. That figure does not account for the grief, nor for what it costs this country to lose productive adults in their middle years to diseases that were, in every meaningful sense, manufactured.
Nigeria is not without legal architecture on this question. The National Tobacco Control Act exists. The WHO Framework Convention on Tobacco Control, to which Nigeria is a signatory, provides a comprehensive policy roadmap that covers everything from advertising bans to plain packaging to taxation floors.
The problem and it is a chronic, structural problem that this newspaper has raised in related contexts before is the chasm between legislation on paper and enforcement in practice. The Act’s provisions on advertising restrictions, point-of-sale display bans, and product regulation have not been implemented with anything approaching the seriousness they demand.
Meanwhile, the emergence of e-cigarettes, vapes and nicotine pouches has exposed regulatory gaps that the original legislation did not anticipate and that no subsequent instrument has adequately closed. The industry, predictably, has moved fastest into precisely those spaces where Nigerian law is most silent.
We urge the Federal Ministry of Health, the National Tobacco Control Authority and the National Agency for Food and Drug Administration and Control(NAFDAC) to treat the regulation of novel nicotine products as a matter requiring immediate and legislative attention.
The governing roadmap is not complicated. Flavoured nicotine products must be banned outright, as several jurisdictions have done without discernible economic catastrophe. Advertising restrictions must be extended explicitly to digital platforms, where the industry’s most effective recruitment of young Nigerians now occurs at a regulatory blind spot so obvious that its continued existence can only reflect captured oversight rather than genuine ignorance.
Excise taxation on tobacco and nicotine products must be substantially increased; the evidence on price sensitivity among adolescent users is unambiguous and has been replicated across dozens of jurisdictions. Cessation services must be expanded so that the millions already addicted have a realistic, accessible pathway out.
We also note, with appreciation, the Nigerian Cancer Society’s establishment of the Youth Coalition Against Cancer, a peer-to-peer influencer platform training young Nigerians to carry prevention messages into their own communities. This is precisely the kind of model that complements regulatory action it meets young people where they actually are, on their own terms, through voices they trust rather than authority figures they instinctively discount.
It deserves government partnership and sustained funding rather than the benign neglect that typically greets civil society health initiatives in this country.
The tobacco industry has always understood something that public health advocates must understand with equal clarity: the fight for the next generation of users is fought and largely decided before those users turn eighteen. The industry invests because it works. Nigeria is running out of time to contest that ground on equal terms. Every year of regulatory drift is a year in which hundreds of thousands of Nigerian children are exposed to products specifically designed to ensure they will need those products for the rest of their lives.
That is not an accident, it is a calculated business model. The laws exist to disrupt that model. The evidence for what works is overwhelming and freely available. What has been missing is the political will to act at the pace the crisis demands. We call on government at all levels to supply it before yet another generation pays with its health for our collective failure to act.
